| Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study AL Sennesael, AS Larock, J Douxfils, L Elens, G Stillemans, M Wiesen, ... Thrombosis journal 16, 1-8, 2018 | 80 | 2018 |
| Predictors of inadequate linezolid concentrations after standard dosing in critically ill patients M Taubert, M Zoller, B Maier, S Frechen, C Scharf, LM Holdt, L Frey, ... Antimicrobial Agents and Chemotherapy 60 (9), 5254-5261, 2016 | 52 | 2016 |
| A physiologically based pharmacokinetic model of voriconazole integrating time-dependent inhibition of CYP3A4, genetic polymorphisms of CYP2C19 and predictions of drug–drug … X Li, S Frechen, D Moj, T Lehr, M Taubert, C Hsin, G Mikus, PJ Neuvonen, ... Clinical Pharmacokinetics 59, 781-808, 2020 | 51 | 2020 |
| The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome C Scharf, U Liebchen, M Paal, M Taubert, M Vogeser, M Irlbeck, M Zoller, ... Journal of Intensive Care 8, 1-10, 2020 | 47 | 2020 |
| Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens M Taubert, J Zander, S Frechen, C Scharf, L Frey, M Vogeser, U Fuhr, ... Journal of Antimicrobial Chemotherapy 72 (8), 2304-2310, 2017 | 28 | 2017 |
| A clinical drug‐drug interaction study assessing a novel drug transporter phenotyping cocktail with adefovir, sitagliptin, metformin, pitavastatin, and digoxin C Trueck, C Hsin, O Scherf‐Clavel, E Schaeffeler, R Lenssen, M Gazzaz, ... Clinical pharmacology & therapeutics 106 (6), 1398-1407, 2019 | 26 | 2019 |
| Drinking ethanol has few acute effects on CYP2C9, CYP2C19, NAT2, and P‐glycoprotein activities but somewhat inhibits CYP1A2, CYP2D6, and intestinal CYP3A: so what? M Gazzaz, M Kinzig, E Schaeffeler, M Jübner, C Hsin, X Li, M Taubert, ... Clinical Pharmacology & Therapeutics 104 (6), 1249-1259, 2018 | 18 | 2018 |
| Enzyme autoinduction by mitotane supported by population pharmacokinetic modeling in a large cohort of adrenocortical carcinoma patients U Arshad, M Taubert, M Kurlbaum, S Frechen, S Herterich, F Megerle, ... European journal of endocrinology 179 (5), 287-297, 2018 | 18 | 2018 |
| Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients U Arshad, M Taubert, T Seeger-Nukpezah, S Ullah, KC Spindeldreier, ... BMC cancer 21, 1-10, 2021 | 16 | 2021 |
| Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients U Arshad, S Ploylearmsaeng, MO Karlsson, O Doroshyenko, D Langer, ... Cancer chemotherapy and pharmacology 85, 711-722, 2020 | 16 | 2020 |
| Using a three-compartment model improves the estimation of iohexol clearance to assess glomerular filtration rate M Taubert, N Ebert, P Martus, M van der Giet, U Fuhr, E Schaeffner Scientific Reports 8 (1), 17723, 2018 | 16 | 2018 |
| Combinations of common SNPs of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxin C Hsin, MS Stoffel, M Gazzaz, E Schaeffeler, M Schwab, U Fuhr, ... Scientific Reports 10 (1), 12457, 2020 | 14 | 2020 |
| Clinical pharmacokinetics and pharmacodynamics of cefiderocol M Bilal, L El Tabei, S Büsker, C Krauss, U Fuhr, M Taubert Clinical Pharmacokinetics 60, 1495-1508, 2021 | 13 | 2021 |
| Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: a phase I trial with early pharmacodynamic FDG‐PET assessment L Nogova, C Mattonet, M Scheffler, M Taubert, M Gardizi, ML Sos, ... Cancer Medicine 9 (14), 4991-5007, 2020 | 13 | 2020 |
| Brain exposure to piperacillin in acute hemorrhagic stroke patients assessed by cerebral microdialysis and population pharmacokinetics S Ullah, R Beer, U Fuhr, M Taubert, M Zeitlinger, A Kratzer, C Dorn, ... Neurocritical Care 33, 740-748, 2020 | 11 | 2020 |
| Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal dose X Li, M Zoller, U Fuhr, M Huseyn-Zada, B Maier, M Vogeser, J Zander, ... Journal of Antimicrobial Chemotherapy 74 (3), 682-690, 2019 | 11 | 2019 |
| The relation between tau pathology and granulovacuolar degeneration of neurons B Puladi, M Dinekov, T Arzberger, M Taubert, C Köhler Neurobiology of disease 147, 105138, 2021 | 10 | 2021 |
| A single dose of baicalin has no clinically significant effect on the pharmacokinetics of cyclosporine A in healthy chinese volunteers R Liu, X Li, J Wei, S Liu, Y Chang, J Zhang, J Zhang, X Zhang, U Fuhr, ... Frontiers in Pharmacology 10, 518, 2019 | 10 | 2019 |
| A Population Pharmacokinetic Model of (R)‐and (S‐) Oxybutynin and Its Active Metabolites After Oral and Intravesical Administration to Healthy Volunteers M Kretschmar, AA Suleiman, P Krause, U Albrecht, R Stein, P Rubenwolf, ... The Journal of Clinical Pharmacology 61 (7), 961-971, 2021 | 9 | 2021 |
| A novel study design using continuous intravenous and intraduodenal infusions of midazolam and voriconazole for mechanistic quantitative assessment of hepatic and intestinal … X Li, L Junge, M Taubert, A von Georg, D Dahlinger, C Starke, S Frechen, ... The Journal of Clinical Pharmacology 60 (9), 1237-1253, 2020 | 5 | 2020 |
Uwe FuhrUniversity of CologneVerified email at uk-koeln.de
